Take on inflammation when treating fibromyalgia suggests evidence review

The role of inflammation in the development, progression and treatment of fibromyalgia is reviewed in Rheumatology International resulting in suggestions for treatment avenues.

There is plenty of evidence showing that fibromyalgia often exists alongside other conditions and diseases – and that inflammation can be a common feature of many of these.

So experts looked at the evidence and found that cytokines/chemokines, lipid mediators, oxidative stress and several plasma-derived factors seem to underlie the inflammatory state in fibromyalgia.

“There are potential new therapeutic options targeting inflammatory pathways in fibromyalgia patients,” the researchers explain. “There is evidence to support the inflammation-driven pathways in the pathogenesis of fibromyalgia.”

Click here to read the original findings

Arthritis Digest Magazine was selected by Feedspot as one of the Top 5 Arthritis Blogs on the internet in 2018.

For more in-depth features, interviews and information, subscribe to Arthritis Digest magazine, a popular title that’s published six times a year. Click here for the digital version or tel 0845 643 8470 to order your had copy. You’ll know what your doctor is talking about, what new drugs are in the pipeline and be up to date on helpful products.